deferoxamine and tempo
deferoxamine has been researched along with tempo in 7 studies
Research
Studies (7)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (71.43) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Beach, DC; Giroux, E | 1 |
| Khan, S; O'Brien, PJ; Ramwani, JJ | 1 |
| Bast, A; van Acker, SA; van Asbeck, BS; van der Vijgh, WJ; Voest, EE | 1 |
| Bartosz, G; Soszyński, M | 1 |
| Bowie, AG; Moynagh, PN; O'Neill, LA | 1 |
| Cadet, J; Douki, T; Duez, P; Favier, A; Gremaud, E; Herbert, K; Hofer, T; Lasserre, L; Ravanat, JL; Saint-Pierre, C | 1 |
| Chao, MR; Hu, CW; Yen, CC | 1 |
Other Studies
7 other study(ies) available for deferoxamine and tempo
| Article | Year |
|---|---|
Inhibition of lipid peroxidation promoted by iron(III) and ascorbate.
Topics: Animals; Antioxidants; Ascorbic Acid; Catalase; Cyclic N-Oxides; Deferoxamine; Edetic Acid; Iron; Kinetics; Lipid Peroxidation; Microsomes, Liver; Oxygen; Rats; Sodium-Potassium-Exchanging ATPase | 1992 |
Hepatocyte toxicity of mechlorethamine and other alkylating anticancer drugs. Role of lipid peroxidation.
Topics: Alkylating Agents; Animals; Antioxidants; Butylated Hydroxyanisole; Cell Death; Cyclic N-Oxides; Deferoxamine; Glutathione; Lipid Peroxidation; Liver; Male; Malondialdehyde; Mechlorethamine; Rats; Rats, Inbred Strains; Vitamin E | 1992 |
Comparison of different iron chelators as protective agents against acute doxorubicin-induced cardiotoxicity.
Topics: Animals; Atrial Function; Cyclic N-Oxides; Deferoxamine; Doxorubicin; Drug Evaluation, Preclinical; Edetic Acid; Heart; Heart Atria; Hydrogen Peroxide; In Vitro Techniques; Iron Chelating Agents; Male; Mice; Mice, Inbred BALB C; Myocardial Contraction; Pyridones; Razoxane | 1994 |
Effect of peroxynitrite on erythrocytes.
Topics: Acetylcholinesterase; Adenosine Triphosphatases; Adult; Cholinesterase Inhibitors; Cyclic N-Oxides; Deferoxamine; Enzyme Inhibitors; Erythrocyte Membrane; Erythrocytes; Glutathione; Hemoglobins; Humans; Lipid Peroxidation; Maleimides; Membrane Lipids; Membrane Proteins; Nitrates; Oxidation-Reduction; Spin Labels; Sulfhydryl Compounds | 1996 |
Lipid peroxidation is involved in the activation of NF-kappaB by tumor necrosis factor but not interleukin-1 in the human endothelial cell line ECV304. Lack of involvement of H2O2 in NF-kappaB activation by either cytokine in both primary and transformed
Topics: Antioxidants; Cell Line, Transformed; Cyclic N-Oxides; Deferoxamine; Endothelium, Vascular; Humans; Hydrogen Peroxide; Interleukin-1; Jurkat Cells; Kinetics; Lipid Peroxidation; NF-kappa B; Pyrrolidines; Siderophores; Spin Labels; Tetradecanoylphorbol Acetate; Thiocarbamates; Tumor Necrosis Factor-alpha | 1997 |
Cellular background level of 8-oxo-7,8-dihydro-2'-deoxyguanosine: an isotope based method to evaluate artefactual oxidation of DNA during its extraction and subsequent work-up.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Antioxidants; Artifacts; Cattle; Cell Fractionation; Chelating Agents; Chemical Precipitation; Chromatography, High Pressure Liquid; Cyclic N-Oxides; Deferoxamine; Deoxyguanosine; DNA; DNA Damage; DNA, Neoplasm; Leukemia, Monocytic, Acute; Liver; Mass Spectrometry; Monocytes; Oxidation-Reduction; Oxygen Isotopes; Rats; Reference Standards; Reference Values; Singlet Oxygen; Sodium Iodide; Thymus Gland; Tumor Cells, Cultured | 2002 |
Prevention of artifactual oxidation in determination of cellular 8-oxo-7,8-dihydro-2'-deoxyguanosine by isotope-dilution LC-MS/MS with automated solid-phase extraction.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Artifacts; Chromatography, Liquid; Cyclic N-Oxides; Deferoxamine; Deoxyguanosine; DNA; Hydrolysis; Mass Spectrometry; Mice; Online Systems; Oxidation-Reduction; Radioisotope Dilution Technique; Solid Phase Extraction | 2008 |